Cargando…

Interventional Oncolytic Immunotherapy with LTX-315 for Residual Tumor after Incomplete Radiofrequency Ablation of Liver Cancer

SIMPLE SUMMARY: Radiofrequency ablation (RFA) is a favorite treatment approach for patients with liver cancer, one of the most common malignancies worldwide. However, incomplete RFA often occurs in irregular and medium-to-larger (>3 cm) hepatic tumors. The aim of this study was to validate the fe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Guanhui, Kan, Xuefeng, Zhang, Feng, Ji, Hongxiu, Sun, Junhui, Yang, Xiaoming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777024/ https://www.ncbi.nlm.nih.gov/pubmed/36551579 http://dx.doi.org/10.3390/cancers14246093

Ejemplares similares

The oncolytic peptide LTX-315 triggers immunogenic cell death
por: Zhou, H, et al.
Publicado: (2016)

Oncolytic peptide LTX-315 induces an immune-mediated abscopal effect in a rat sarcoma model
por: Nestvold, Janne, et al.
Publicado: (2017)

The oncolytic peptide LTX-315 induces cell death and DAMP release by mitochondria distortion in human melanoma cells
por: Eike, Liv-Marie, et al.
Publicado: (2015)

The oncolytic peptide LTX-315 kills cancer cells through Bax/Bak-regulated mitochondrial membrane permeabilization
por: Zhou, Heng, et al.
Publicado: (2015)

Understanding the Biophysical Interaction of LTX-315 with Tumoral Model Membranes
por: Klaiss-Luna, Maria C., et al.
Publicado: (2022)

Combining the oncolytic peptide LTX-315 with doxorubicin demonstrates therapeutic potential in a triple-negative breast cancer model
por: Camilio, Ketil A., et al.
Publicado: (2019)

LTX-315 – a promising novel antitumor peptide and immunotherapeutic agent
por: Zweytick, Dagmar
Publicado: (2019)

Injectable hydrogel loaded with lysed OK-432 and doxorubicin for residual liver cancer after incomplete radiofrequency ablation
por: Cao, Yanyan, et al.
Publicado: (2023)

Anticancer effect obtained against MCA205 sarcoma following treatment with the oncolytic peptide LTX-315 in combination with immune checkpoint inhibitors
por: Rekdal, Öystein, et al.
Publicado: (2015)

Oncolytic peptide LTX-315 induces anti-pancreatic cancer immunity by targeting the ATP11B-PD-L1 axis
por: Tang, Tianyu, et al.
Publicado: (2022)

LTX-315 sequentially promotes lymphocyte-independent and lymphocyte-dependent antitumor effects
por: Liao, Hsin-Wei, et al.
Publicado: (2019)

Correction: Injectable hydrogel loaded with lysed OK-432 and doxorubicin for residual liver cancer after incomplete radiofrequency ablation
por: Cao, Yanyan, et al.
Publicado: (2023)

LTX-315 (Oncopore™): A short synthetic anticancer peptide and novel immunotherapeutic agent
por: Camilio, Ketil André, et al.
Publicado: (2014)

LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells
por: Yamazaki, Takahiro, et al.
Publicado: (2021)

Enhanced T-lymphocyte infiltration in a desmoid tumor of the thoracic wall in a young woman treated with intratumoral injections of the oncolytic peptide LTX-315: a case report
por: Jebsen, Nina Louise, et al.
Publicado: (2019)

Enhanced efficacy of direct immunochemotherapy for hepatic cancer with image-guided intratumoral radiofrequency hyperthermia
por: Kan, Xuefeng, et al.
Publicado: (2022)

Complete regression and systemic protective immune responses obtained in B16 melanomas after treatment with LTX-315
por: Camilio, Ketil André, et al.
Publicado: (2014)

Cell cycle progression data on human skin cancer cells with anticancer synthetic peptide LTX-315 treatment
por: Santa-González, Gloria A., et al.
Publicado: (2020)

Biophysical Characterization of LTX-315 Anticancer Peptide Interactions with Model Membrane Platforms: Effect of Membrane Surface Charge
por: Koo, Dong Jun, et al.
Publicado: (2022)

The Novel Oncolytic Compound LTX-401 Induces Antitumor Immune Responses in Experimental Hepatocellular Carcinoma
por: Mauseth, Brynjar, et al.
Publicado: (2019)

Inflammation induced by incomplete radiofrequency ablation accelerates tumor progression and hinders PD-1 immunotherapy
por: Shi, Liangrong, et al.
Publicado: (2019)

Interventional Optical Imaging-Monitored Synergistic Effect of Radio-Frequency Hyperthermia and Oncolytic Immunotherapy
por: Zheng, Hui, et al.
Publicado: (2022)

Ultrasonic Cavitation Ameliorates Antitumor Efficacy of Residual Cancer After Incomplete Radiofrequency Ablation in Rabbit VX2 Liver Tumor Model()
por: Li, Shi-yan, et al.
Publicado: (2019)

Incomplete radiofrequency ablation accelerates proliferation and angiogenesis of residual lung carcinomas via HSP70/HIF-1α
por: Wan, Jun, et al.
Publicado: (2016)

Evolution of Indications for Liver Transplantation (LTx) in the Years 2001–2017 in Poland
por: Koczkodaj, Paweł, et al.
Publicado: (2019)

Intratumoral treatment of one tumor lesion with LTX-315 induces complete tumor regression and long-term specific protective immune responses in a metastatic rodent tumor model
por: Rekdal, Öystein, et al.
Publicado: (2014)

An Overview of Hepatocellular Carcinoma After Insufficient Radiofrequency Ablation
por: Guo, Yusheng, et al.
Publicado: (2022)

Incomplete Radiofrequency Ablation Enhances Invasiveness and Metastasis of Residual Cancer of Hepatocellular Carcinoma Cell HCCLM3 via Activating β-Catenin Signaling
por: Zhang, Ning, et al.
Publicado: (2014)

Correction: Incomplete Radiofrequency Ablation Enhances Invasiveness and Metastasis of Residual Cancer of Hepatocellular Carcinoma Cell HCCLM3 via Activating β-Catenin Signaling
Publicado: (2015)

Integrated proteogenomic characterization reveals an imbalanced hepatocellular carcinoma microenvironment after incomplete radiofrequency ablation
por: Shi, Zheng-Rong, et al.
Publicado: (2023)

Comparison of Wet Radiofrequency Ablation with Dry Radiofrequency Ablation and Radiofrequency Ablation Using Hypertonic Saline Preinjection: Ex Vivo Bovine Liver
por: Lee, Jeong Min, et al.
Publicado: (2004)

Incomplete radiofrequency ablation provokes colorectal cancer liver metastases through heat shock response by PKCα/Fra-1 pathway
por: Zhang, Zhanguo, et al.
Publicado: (2019)

Neoadjuvant Use of Oncolytic Herpes Virus G47Δ Enhances the Antitumor Efficacy of Radiofrequency Ablation
por: Yamada, Tomoharu, et al.
Publicado: (2020)

Effect of Ultrasound-Guided Radiofrequency Ablation in Incompletely Treated Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization
por: Chang, Nam Kyu, et al.
Publicado: (2012)

Tetrahydrofurandiols (THF-diols), Leukotoxindiols (LTX-diols), and Endocrine Disruption in Rats
por: Markaverich, Barry M., et al.
Publicado: (2007)

Gangliosides Block Aggregatibacter Actinomycetemcomitans Leukotoxin (LtxA)-Mediated Hemolysis
por: Forman, Michael S., et al.
Publicado: (2010)

Stereotactic Radiofrequency Ablation of Liver Tumors in Octogenarians
por: Schullian, Peter, et al.
Publicado: (2019)

Oncolytic Virus Immunotherapy
por: Marchini, Antonio, et al.
Publicado: (2021)

Residues 315 and 369 in HN Protein Contribute to the Thermostability of Newcastle Disease Virus
por: Ruan, Baoyang, et al.
Publicado: (2020)

Is Incomplete Left Atrial Posterior Wall Isolation Associated With Recurrence of Atrial Fibrillation After Radiofrequency Catheter Ablation?
por: Fujito, Takefumi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_krksu651jbuttagi55fs4h602a